Current Treatment Strategies 2024 Westgate Las Vegas Resort & Casino
June 10-12 2025
More ...
“I am thankful that she told us about the latest guidelines that were updated 2 days ago.
This was a really good presentation. It made me realize I need to brush up on my CKD knowledge, especially in the setting of anemia and Bone-Mineral Density.
The presenter was knowledgeable and displayed her expertise in the practice setting”
-
1. Define what “palliative care” is and state the overall pharmacological goals of palliative care. 2. State common symptoms experienced by palliative care patients with the following diseases: (a) Cancer; (b) COPD; (c) Renal disease; (d) Liver disease; (e) ALS; (f) Parkinson’s disease.
3. Compare and contrast core pharmacological principles for the use of opioids in palliative care patients versus hospice patients.
4. Describe best practice for use of common pain medications including agent selection, dosing, titration, routes of administration and common side effects of: Opioids (morphine, methadone, fentanyl, oxycodone, hydrocodone, hydromorphone and buprenorphine) Adjuvants such as NSAIDS, anti-depressants, anticonvulsants.
5. Propose a pharmacological management strategy for each of the following symptoms: (a) nausea and vomiting (b) dyspnea (c) mental status changes (anxiety, agitation, hallucinations) (d) constipation (e) pruritus (f) insomnia (g) anorexia; cachexia (h) weakness and fatigue (i) muscle spasms.
6. Cite four general principles for medication optimization (deprescribing) to improve the pharmacological outcomes of palliative care patients.
-
1. Illustrate the physiological effects of hyperinsulinemia and insulin resistance in the pathogenesis of type 2 diabetes.
2. Explain the relationship between insulin and the medications used to treat type 2 diabetes in the context of hyperinsulinemia and insulin resistance.
3. Summarize the evidence for Therapeutic Carbohydrate Restriction (TCR) for people with type 2 diabetes.
4. Recognize the appropriate management of type 2 diabetes patients with both medication and lifestyle interventions.
5. Demonstrate the various modes of critical thinking to Type 2 diabetes treatment.
6. Apply the tools of Evidence Based Medicine to personalize diabetes treatment.
-
New Drugs Parts 1 and 2:
1. Identify 10 – 20 new medications .
2. Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.
3. Discuss updates related to labeling, indications, risks associated with various medications
Pediatric Pharmacotherapeutics:
4. Identify ways in which children are different than adults in terms of pharmacotherapeutics .
5. Discuss common pediatric prescribing errors.
6. Discuss strategies to prevent pediatric prescribing errors.
7. Identify medications with new pediatric approvals.
CKD Treatment in Primary Care
8. Recognize CKD in patients with reduced kidney function, including in early stages of disease. 9) Implement screening for albuminuria in patients with diabetes in clinical practice to identify CKD as early as possible.
9. Describe therapy with evidence-based therapies, including newer agents, for patients with CKD when indicated.
Prescribing Safely-Avoiding Malpractice and Litigation
10. Discuss the most common mechanisms for drug-drug interactions .
11. Discuss techniques to ensure safe prescribing .
12. Review cases involving prescribing errors and medical malpractice cases .
About This Course
This on demand course was recorded live in Westgate Resort and Casino where Las Vegason June 11-13 2025. It provides 15 hours. live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/ CME credit.
Price $299
Dr. Gregory L. Holmquist, PharmD, CPE
Dr. Holmquist received his undergraduate and graduate degrees from the School of Pharmacy at the University of Washington in Seattle. He is a board certified Oncology Pharmacist, an American Medical Association Certified Educator for Physicians on Endof-Life Care, and an American Society of Pain Educators Certified Pain Educator (C.P.E.). As a clinician and educator, Dr. Holmquist’s philosophy of care is summarized in one core statement, “Making a difference in the lives of patients”
Dr. WENDY L. WRIGHT, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
Wendy received her Doctor of Nursing Practice in 2019 from the University of Alabama, Tuscaloosa. She is a 1992 graduate of the Adult Primary Care Nurse Practitioner program at Simmons College in Boston, Massachusetts and completed a family nurse practitioner post-master’s program in 1995. She is an adult and family nurse practitioner and the owner of two, nurse practitioner owned and operated clinics within New Hampshire.
Cory Jenks PharmD, BCPS, BCACP
Ambulatory Care Clinical Pharmacy Specialist, Southern Arizona VA Healthcare System, Tucson, AZ,Independent speaker and teacher:How to apply the skills of improv comedy to create a more adaptable, empathetic, and humanizing healthcare experience. Dr. Jenks has no disclosures.
TARGET AUDIENCE/ ACCREDITATION
PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists.
NURSE PRACTITIONERS/ NURSES: This course provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, to fulfill the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours for certification renewal. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE). .
PHYSICIANS: The AAFP has reviewed Providing Better Patient Care June 10-12, 2025 and deemed it acceptable for up to 15.00 AAFP Prescribed credit(s). Term of Approval is from 06/10/2025 to 06/12/2028. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA).
PHYSICIAN ASSISTANTS: American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.